Our Efforts to Develop a COVID-19 Vaccine

Health
VaccineFeatureLead_790x500.jpg
VaccineFeatureLead_1000x450.jpg

Our Efforts to Develop a COVID-19 Vaccine

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES

Our People
Get to know DR. Annaliesa Anderson
Get to know DR. Annaliesa Anderson

GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES

Find out what life is like for her, and our other scientists, in the time of coronavirus.

PROFESSOR JOE SCHMITT TALKS TICK-BOURNE ENCEPHALITIS

Health
TBE_Image_380x500.jpg
TBE_Image_1000x450.jpg

PROFESSOR JOE SCHMITT TALKS TICK-BOURNE ENCEPHALITIS

Ticks may be tiny, but the diseases they carry can have a big impact.

HOW ARE VACCINES DEVELOPED?

Our Science
How are vaccines Developed?
How are vaccines Developed?

HOW ARE VACCINES DEVELOPED?

Explore what it takes to develop a novel vaccine.

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

COVID-19 AND CANCER

Your Health
COVID-19 and Cancer
COVID-19 and Cancer

COVID-19 AND CANCER

We answer questions about the impact of Coronavirus on people with cancer, safeguards they can take to stay healthy & more.

WHAT YOU NEED TO KNOW ABOUT COVID-19

Your Health
What you need to know about COVID-19
What you need to know about COVID-19

WHAT YOU NEED TO KNOW ABOUT COVID-19

Practical advice to protect you and your family from coronavirus.

Latest News

-Abrocitinib met all key endpoints, demonstrating statistically superior improvements in skin clearance, disease extent and severity, and itch compared to placebo- -Safety profile consistent with other pivotal studies of abrocitinib reported to date- Pfizer Inc. (NYSE: PFE) announced today that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in…